Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease

University of Florida · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
hematopoietic-stem-cell-transplantationleukemiamyeloid
leukemia, myeloid, myelodysplastic syndromes, lenalidomide, hematopoietic stem cell transplantation, peripheral blood stem cell transplantation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 803198
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.